56 results
DEFA14A
ALGS
Aligos Therapeutics Inc
29 Apr 24
Additional proxy soliciting materials
4:04pm
Materials
Soliciting Material under §240.14a-12
ALIGOS THERAPEUTICS, INC.
(Name of Registrant as Specified in its Charter)
(Name of Person(s … with preliminary materials
Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11
P.O. BOX 8016, CARY, NC 27512
PRE 14A
ALGS
Aligos Therapeutics Inc
16 Apr 24
Preliminary proxy
5:27pm
Materials
Soliciting Material under §240.14a-12
ALIGOS THERAPEUTICS, INC.
(Name of Registrant as Specified in its Charter)
(Name of Person(s … with preliminary materials
Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11
ALIGOS THERAPEUTICS, INC
SC TO-I
EX-99
01adwudw o0chu
30 Jan 24
Issuer tender offer statement
7:04am
SC TO-I
EX-99
35l3afml
30 Jan 24
Issuer tender offer statement
7:04am
SC TO-I
EX-99
08q3x 87xaz9
30 Jan 24
Issuer tender offer statement
7:04am
SC TO-I
EX-99
9pbs5c f805iw
30 Jan 24
Issuer tender offer statement
7:04am
SC TO-I
EX-99
4wu29 bhe
30 Jan 24
Issuer tender offer statement
7:04am
SC TO-I
EX-99
0beo6uzzotfkrv ae
30 Jan 24
Issuer tender offer statement
7:04am
SC TO-I
EX-99
xnq6esnbhyu7ecii33
30 Jan 24
Issuer tender offer statement
7:04am
SC TO-I
EX-99
wxw26h5yjid2qcdp9h7
30 Jan 24
Issuer tender offer statement
7:04am
SC TO-C
ra0h28e4dqt1a0xsy8
25 Jan 24
Information about tender offer
6:12am
8-K
EX-99.1
v24d1n
25 Jan 24
Other Events
6:06am
8-K
9297t2ticvb 5q2
25 Jan 24
Other Events
6:06am
D
zfx q4pkk6akrwprb
7 Nov 23
$92.15 mm in equity / options / securities to be acquired, sold $92.15 mm, 11 investors
12:03pm
8-K
EX-10.1
knw5o36
25 Oct 23
Entry into a Material Definitive Agreement
5:05pm